UNIVERSAL CELLS, INC.

SEATTLE, WA · Founded 2013 · CIK 0001613654 · Biotech · Acquired

MHC-negative pluripotent stem cells engineered for universal donor transplantation without immune rejection

universalcells.com →
Grants
$793K
1 award
Sector median: 1
Raised
$60K
1 Form D · Jul 2014
147 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$60,000
Federal grantDepartment of Health and Human Services · Phase II · In vivo validation of Universal Donor Cells$792,747
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2660CINDER BIOLOGICAL, INC.—$100K
2661Nano Pharmasolutions Inc.—$75K
2662Normunity——
2663UNIVERSAL CELLS, INC.—$60K
2664ISPIN, INC.——
2665Path BioAnalytics, Inc.——
2666Amicus Inc. / DE—$50K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 2 related persons
  • Claudia MitchellExecutive Officer
  • David RussellDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.